1. Home
  2. RGEN vs WWD Comparison

RGEN vs WWD Comparison

Compare RGEN & WWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • WWD
  • Stock Information
  • Founded
  • RGEN 1981
  • WWD 1870
  • Country
  • RGEN United States
  • WWD United States
  • Employees
  • RGEN N/A
  • WWD N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • WWD Industrial Machinery/Components
  • Sector
  • RGEN Health Care
  • WWD Energy
  • Exchange
  • RGEN Nasdaq
  • WWD Nasdaq
  • Market Cap
  • RGEN 7.6B
  • WWD 10.4B
  • IPO Year
  • RGEN N/A
  • WWD N/A
  • Fundamental
  • Price
  • RGEN $156.55
  • WWD $184.10
  • Analyst Decision
  • RGEN Buy
  • WWD Buy
  • Analyst Count
  • RGEN 12
  • WWD 9
  • Target Price
  • RGEN $187.44
  • WWD $195.38
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • WWD 381.9K
  • Earning Date
  • RGEN 02-19-2025
  • WWD 01-27-2025
  • Dividend Yield
  • RGEN N/A
  • WWD 0.54%
  • EPS Growth
  • RGEN N/A
  • WWD 58.99
  • EPS
  • RGEN N/A
  • WWD 6.01
  • Revenue
  • RGEN $633,513,000.00
  • WWD $3,324,249,000.00
  • Revenue This Year
  • RGEN $2.28
  • WWD $3.60
  • Revenue Next Year
  • RGEN $9.88
  • WWD $7.96
  • P/E Ratio
  • RGEN N/A
  • WWD $29.97
  • Revenue Growth
  • RGEN N/A
  • WWD 14.06
  • 52 Week Low
  • RGEN $113.50
  • WWD $133.56
  • 52 Week High
  • RGEN $211.13
  • WWD $201.64
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • WWD 63.72
  • Support Level
  • RGEN $149.15
  • WWD $176.39
  • Resistance Level
  • RGEN $160.64
  • WWD $182.66
  • Average True Range (ATR)
  • RGEN 5.96
  • WWD 3.84
  • MACD
  • RGEN 0.91
  • WWD 1.36
  • Stochastic Oscillator
  • RGEN 79.57
  • WWD 96.10

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About WWD Woodward Inc.

Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and services reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servo controls, motors, and sensors for aircraft. The Industrial segment offers actuators, valves, pumps, fuel injection systems, solenoids, ignition systems, speed controls, electronics and software, and sensors.

Share on Social Networks: